Epigenetic modifications may play an important role in the formation and progression of complex diseases through the regulation of gene expression. The systematic identification of epigenetic variants that contribute to human diseases can be made possible using genome-wide association studies (GWAS), although epigenetic effects are currently not included in commonly used case^control designs for GWAS. Here, we show that epigenetic modifications can be integrated into a case^control setting by dissolving the overall genetic effect into its different components, additive, dominant and epigenetic. We describe a general procedure for testing and estimating the significance of each component based on a conventional chi-squared test approach. Simulation studies were performed to investigate the power and false-positive rate of this procedure, providing recommendations for its practical use. The integration of epigenetic variants into GWAS can potentially improve our understanding of how genetic, environmental and stochastic factors interact with epialleles to construct the genetic architecture of complex diseases.
INTRODUCTION
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One of the key challenges facing geneticists is how to design a powerful experiment that can capitalize on epigenetic data and detect significant epigenetic variants that are associated with complex diseases. Several authors have proposed linkage or association mapping strategies to identify the amount and pattern of quantitative variation determined by epialleles, a group of identical genes that differ in the extent of methylation [11] and retrieve epigenetic variation that cannot be estimated presently [12] [13] [14] [15] . For example, covariances between relatives due to epigenetic transmissibility have been derived by Tal et al. [16] . By making crosses derived from epigenomically perturbed isogenic lines, Johannes and Colome-Tatche [17] developed an approach to estimating epigenetic variation, allowing the effects of epiallelic instability, recombination, parent-oforigin effects and transgressive segregation to be characterized. Wang et al. [18] integrated conventional quantitative genetic theory with DNA methylation mechanisms to provide an approach for quantifying epigenetic effects and variation in complex traits.
Given its popularity in candidate-gene association studies and genome-wide association studies (GWAS), a case-control design that compares genetic variants in a group of diseased individuals versus a group of unrelated controls has proven to be powerful for detecting and estimating the genetic variants that affect complex diseases. However, there have been no studies that can integrate epigenetic control into a case-control setting, making it impossible to elucidate a comprehensive picture of the genetic architecture of complex diseases. In this article, we show that epigenetic variants can be identified within the case-control context and provide a general procedure for testing and estimating epigenetic variation in human diseases. Epigenetic modifications can appear in multiple forms, but most studied form is DNA methylation [19] . As its most common feature, DNA methylation may occur: (i) at a cytosine-guanine dinucleotides (CpG) site [20] , at which some cytosines within a CpG dinucleotide are methylated by adding a methyl group to the fifth position of the cytosine pyrimidine ring and (ii) at multiple adjacent CpG sites with varying lengths [21] . Variation in DNA methylation at a single or multiple sites is called a methylation variable position (MVP) and a differentially methylated region (DMP), respectively. By considering MVP or DMP as the epigenetic equivalent of a SNP or multiple SNPs, Wang et al. [18] are able to separate and estimate the genetic and epigenetic contributions to a complex trait using a quantitative genetic and epigenetic theory. Here, we test each of these two types of contributions in a case-control design. It is our hope that the integration of epigenetic control with case-control studies provides useful guidance for designing efficient and effective GWAS to characterize a comprehensive picture of the epigenetic variation of diseases.
DESIGN Modeling genetic and epigenetic effects
The quantitative epigenetic model is founded on the classic theory of quantitative genetics [22, 23] . To clearly describe our model, we first consider DNA methylation at a CpG site. Similar procedures can be derived for DNA methylation with multiple alleles and at multiple sites, as commonly observed in practice [19] [20] [21] . At this methylated site, two alleles A 1 and A 2 are assumed. The two alleles produce three genotypes, A 1 A 1 , A 1 A 2 and A 2 A 2 , in a natural population. We use a to denote the additive effect of the nucleotide site due to the substitution of allele A 1 by A 2 or vice versa and d to denote the dominant effect due to the interaction between the two alleles. We express diagrammatically the values of three genotypes over an axis as follows:
Suppose there is a particular environmental signal that drives one of the alleles (say A 1 ) to be methylated, leading to six distinguishable genetic and epigenetic types whose genotypic values and observations are expressed as Genotype=epigenotype Expected value Observation 
n 11 n 1e n ee 8 < :
where the genotypic value of the trait is decomposed into different components, i.e. the overall mean (m), (2)],
In an epigenetic study, much effort is given to test the epigenetic effect of the nucleotide site, a e , and dominant effects due to the interactions between the alleles and epiallele, d 1e and d 2e . Next, we use a casecontrol design to test each of the genetic and epigenetic effects from Equations (3) to (7).
Contingency tables
From a natural human population, we draw two groups of subjects at random. One group includes n diseased individuals, whereas the second group has m controls with no disease. It is assumed that cases and controls are matched for age, sex, ethnicity, geographical location and environmental factors. All the cases and controls are genotyped for the same set of nucleotide sites, at each of which an allele is methylated to an epiallele. Based on the genotype/epigenotypes, we classify all the observations for the case and control into a (2 Â 6) contingency table as follows: Let p ij denote the actual frequency of observations in the ith row (i ¼ 1 for cases and 2 for controls) and jth column (j ¼ 1 for A 1 A 1 , . . . , 6 for A 2 A 2 ), let p iþ and p þj denote column and row marginals, respectively, and let p þþ denote the grand total. If the genotypes/ epigenotypes are independent of the disease, then the probability of being in p ij is simply the product of the probability of being in marginal category i and j, expressed as
A Pearson statistic for testing the genotype/epigenotype-disease association can be calculated by
which follows a chi-square distribution with
0:05ðdf ¼5Þ , this suggests that the genotypes/epigenotypes are significantly associated with the disease. Otherwise, there is no significant association between the genotypes/epigenotypes and the disease.
Testing and estimating genetic and epigenetic effects
Combining the principle of analyzing the contingency table [Equation (8) The contingency table for testing the dominance effect (d 12 ) due to the interaction between wild-type alleles A 1 and A 2 is expressed as
, respectively. Since cell counts in contingency tables [Equations (10)- (14)] are formed by a weighted combination of original observed cell counts, these test statistics may not obey a chi-square distribution with 1 degree of freedom. Liu et al. [24] have proved that under the null hypothesis, these test statistics are asymptotically smaller than w 2 0:05ðdf ¼1Þ . They further derived an approximation approach for determining the critical thresholds.
The effect sizes of a 1 , a e , d 1e , d 12 and d 2e are estimated by odds ratios (ORs). A general form of contingency tables [Equations (10)- (14)] is expressed as the joint distribution of two binary random variables X and Y, i.e.
from which an OR is calculated aŝ
describing the extent to which the two variables are related through a particular genetic or epigenetic effect. OR ¼ 1 suggests no relationship. The confidence interval of the OR effect value is calculated as e lnÔR AE zÁSE , where z is a standard normal deviate corresponding to the level of confidence (z ¼ 1.96, 2.576 for 95 and 99% confidence, respectively), and SE is the estimated standard deviation of the log OR calculated as SE ¼ ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
MODEL DEMONSTRATION AND VALIDATION
The epigenetic model was demonstrated and validated through simulation studies. Suppose there is a case population in which a nucleotide site has two alleles A 1 and A 2 , with frequencies p and 1 À p, respectively. The allele A 1 is methylated into an epiallele A e at a rate u. Through DNA methylation, allele frequencies will change; i.e., the frequencies of non-methylated A 1 allele, epiallele A e and allele A 2 are (1 À u)p, up and 1 À p, respectively. 
where D 12 , D 1e and D 2e are the coefficients of Hardy-Weinberg disequilibrium (HWD) due to a non-random association between alleles A 1 and A 2 , between allele A 1 and epiallele A e and between allele A 2 and epiallele A e , respectively. The genotype and epigenotype frequencies may be determined by allele and epiallele frequencies and HWD coefficients. It is possible that DNA methylation violates the previous equilibrium of the population, with the HWD quantified by D 12 , D 1e and D 2e , whose intervals are given as
A similar situation holds for the control population.
The model was tested under four different scenarios. The first is to assume that both case and control populations have the same methylation occurrence rate and HWD coefficients. In the second scenario, the case population is assumed to have a larger occurrence rate than the control population, with the other parameters being identical. The third scenario is reciprocal in parameter design to the second one.
The last scenario assumes no HWD, although methylation occurs at the same rate for both populations. All parameter values for the four scenarios are given in Table 1 , with which to calculate genotype/ epigenotype frequencies and then simulate contingency table [Equation (8)]. The sample size considered is 500 cases þ 500 controls, 2000 cases þ 2000 controls and 5000 cases þ 5000 controls.
Epigenetic effects contain three different components, the additive effect due to the substitution of epiallele A e by allele A 2 (a e ) and the dominance effects due to the interaction between allele A 1 and epiallele A e (d 1e ) and between allele A 2 and epiallele A e (d 2e ). The power and false-positive rates of detecting each of these components from the model are investigated. To do that, we simulated the count data in contingency table [Equation (8)] by assuming different OR for each case. The OR describes and quantifies the extent to which the two categories are related. Values of OR ¼ 1, 1.6, 1.9 and 2.2 are regarded as no effect, small effect, moderate effect and large effect, respectively. The count data were simulated under each of these values. Note that, in order to simulate the data under these OR constraints, we relax the allele frequency of allele A 1 in the case population.
The simulated data were analyzed by the epigenetic model, from which to calculate test statistics, w , under different effect sizes. In each case, simulation was replicated 1000 times, which were used to calculate the power for epigenetic effect detection for the data of OR > 1 and false-positive rates for the data of OR ¼ 1. In general, even for a small sample size (500 cases þ 500 controls), the model has good power (>0.80) to detect any size of epigenetic dominant effect d 2e under each scenario, while having reasonably low false-positive rates (<0.06) ( Table 2 ). There is adequate power to detect the additive effect of epiallele when a moderate sample is used (2000 cases þ 2000 controls). To detect a small epigenetic dominant effect d 1e , we need a large sample size (5000 cases þ 5000 controls). It should be pointed out that the model cannot detect epigenetic dominant effect d 1e under 1  3  4  0  98  51  100  100  81  100  100  100  100  2  3  1  3  86  80  100  99  99  100  100  100  100  3  6  4  2  100  41  100  100  77  100  100  94  100  4  3  4  0  64  2  100  82  3  100  95  1  100 Note: a e is the additive effect due to the substitution of epiallele A e by allele A 2 , d 1e and d 2e are the dominance effects due to the interaction between allele A 1 and epiallele A e and between allele A 2 and epiallele A e , respectively.
Scenario 4 in which case this effect parameter is canceled out. The false-positive rates are always low for any sample size under any simulation scenario.
DISCUSSION
Given their tremendous importance in contributing to genetic variation and adapting to environmental perturbations, epigenetic alterations have been increasingly studied, mostly focusing the molecular characterization of the underlying formation mechanisms [19-21, 25, 26] . Although this has helped greatly to improve our understanding of the origin of epigenetic alterations, a systematic detection of this phenomenon through GWAS in a commonly used case-control design is still not largely feasible [19] . Here, we have integrated quantitative genetic and epigenetic principles established by Wang et al.
[18] into a case-control setting, allowing the significance of genetic and epigenetic effects on a disease to be tested and analyzed. In the previous studies, quantitative genetic principles were incorporated with a case-control design to analyze the associations between epistasis and disease [27, 28] . By defining various types of genetic and epigenetic effects, the approach described reformats casecontrol observational data into a 2 Â 2 contingency table and then tests the associations between different genotypes or epigenotypes and disease using Pearson test statistics. An OR is calculated to estimate genetic and epigenetic effects on disease. This approach is more advantageous over a classic log-linear regression approach in many aspects. First, it is computationally simple and efficient based on statistical analyses of individual 2 Â 2 contingency tables. As shown by simulation studies in Liu et al. [24] , a log-linear approach incorporates all possible factors into a single model, which is easily intractable when the number of factors increases. Second, the new approach integrates quantitative genetic principles into a case-control setting, allowing statistical inference to be more biologically meaningful over that from classic approaches. Third, the approach described can be readily extended to any complicated situation, in which genetic and epigenetic effects arising from multiple methylated sites as well as the interactions between these effects and environmental factors are important contributors to disease. The approach presented is capable of testing the components of epigenetic effects including the additive effect of the methylated epiallele (a e ) and the dominant effects between the epiallele and wild-type alleles (d 1e and d 2e ). It is possible that epigenetic alterations trigger the disease singly or jointly through these different effect types [29] . For a particular casecontrol data set, the model allows the test and estimation of each of these effects. We performed a set of simulation studies to investigate the statistical properties of the model in analyzing and detecting epigenetic effects for a practical case-control data set. The results from the simulation demonstrate the utilization and usefulness of the model.
To better describe the principle of epigenetic analysis in a case-control study, we considered only a single methylated CpG site for model derivations at a time. However, given the complexity of trait inheritance, one can expect that multiple sites are methylated simultaneously, giving rise to a complex network of genetic and epigenetic interactions. There is no technical difficulty in extending the model to include two or more sites that may interact with each other, although its solution needs powerful computational facility. For two methylated sites, we need to handle a total of 25 interactions between parameter set (a 1 , a e , d 1e , d 2e , d 12 ) from each site. In some particular case, epigenetic contribution contains a series of pathways, therefore stimulating our model derivation to include high-order interactions [27] . Also, there are many other mechanisms, such as histone modifications and non-coding RNA modifications, that cause epigenetic perturbations [19] . In some cases, an epiallele can modify the expression of an allele, creating a spectrum of alleles that are functionally diverse [30] . All these epigenetic mechanisms and forms can be integrated into our model, with observational data rearranged in terms of 2 Â 2 contingency tables, to better chart an entire picture of epigenetic regulation for complex diseases.
The expression of epigenetic effects is environment dependent [26, 31] . Epigenotype-environment interactions should be included in our model to better unravel the etiology of epigenetic formation and its impact on complex diseases. Recent studies show that epigenetic modifications may be reprogrammed during meiosis or transmitted from generation to generation [32, 33] . Such a dynamic feature of epigenetic modifications can be tested by developing a family-based case-control design. Currently, GWAS have been increasingly used in genetic research in light of their power to comprehend the genetic control of complex traits or diseases. Stimulated by GWAS, epigenome-wide association studies (EWAS) have arisen as a new approach, during the past few years, to systematically study epigenetic control [34, 35] , and there is now a trend to merge GWAS and EWAS [19] into a single design for dissecting the genetic regulation of complex traits or diseases. Statistical high-dimensional models for analyzing all SNPs at the same time in GWAS have now been available [36] , which can be extended to capture genome-wide epigenetic control. There is no doubt that a new high-dimensional model for EWAS will enable geneticists to draw a more comprehensive picture of the epigenetic landscape for complex human diseases [19] .
Key points
Epigenetic modifications through DNA methylation, chromatin remodeling, histone modification or RNA interference have been thought to play a pivotal role in generating and maintaining new quantitative genetic variation. There is a pressing need on developing quantitative models that can identify and estimate epigenetic variants that contribute to complex diseases, gleaning new insight into the pattern and form of epigenetic variation. We integrate quantitative genetic and epigenetic principles into a case^control study framework to test the inheritance mode of genetic and epigenetic variants from GWAS. The integrative model facilitates the detection of epigenetic variants involved in human diseases.
